These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2521197)

  • 1. A simple method to detect and estimate heterogeneity: application to Huntington disease, diabetes, and HIV seroconversion.
    Payami H
    Am J Hum Genet; 1989 Jan; 44(1):107-14. PubMed ID: 2521197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-of-onset heterogeneity in Huntington disease families.
    Pericak-Vance MA; Elston RC; Conneally PM; Dawson DV
    Am J Med Genet; 1983 Jan; 14(1):49-59. PubMed ID: 6219581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using survival methods to estimate age-at-onset distributions for genetic diseases with an application to Huntington disease.
    Cupples LA; Terrin NC; Myers RH; D'Agostino RB
    Genet Epidemiol; 1989; 6(2):361-71. PubMed ID: 2524419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus in Huntington disease.
    Farrer LA
    Clin Genet; 1985 Jan; 27(1):62-7. PubMed ID: 3156696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.
    Fowke KR; Nagelkerke NJ; Kimani J; Simonsen JN; Anzala AO; Bwayo JJ; MacDonald KS; Ngugi EN; Plummer FA
    Lancet; 1996 Nov; 348(9038):1347-51. PubMed ID: 8918278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of auxiliary events to improve the analysis of survival for HIV-infected patients: application to the French Prospective Multicenter Cohort (SEROCO).
    Flandre P; Boufassa F; Gerard L; Carré N; Persoz A; Meyer L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):174-81. PubMed ID: 8680889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts.
    Bellan SE; Dushoff J; Galvani AP; Meyers LA
    PLoS Med; 2015 Mar; 12(3):e1001801. PubMed ID: 25781323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age at seroconversion on the natural AIDS incubation distribution. Multicenter Hemophilia Cohort Study and the International Registry of Seroconverters.
    Rosenberg PS; Goedert JJ; Biggar RJ
    AIDS; 1994 Jun; 8(6):803-10. PubMed ID: 8086140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV seroconversion among Baltimore City residents tested at a mobile van programme.
    Puryear S; Burnett P; Page KR; Muvva R; Chaulk P; Ghanem KG; Monroe A
    Sex Transm Infect; 2018 Feb; 94(1):37-39. PubMed ID: 28899995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Factors for HIV Seroconversion Among Individuals Attending a Specialized Center After an HIV Risk Exposure: A Case-Control Study.
    Leal L; Torres B; León A; Lucero C; Inciarte A; Diaz-Brito V; de Lazzari E; Gatell JM; García F
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1016-1021. PubMed ID: 27457508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing genetic effects in survival data by correlating martingale residuals with an application to age at onset of Huntington disease.
    Wintrebert CM; Zwinderman AH; Maat-Kievit A; Roos RA; van Houwelingen HC
    Stat Med; 2006 Sep; 25(18):3190-200. PubMed ID: 16416406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the G8 probe in predicting risk of Huntington disease.
    Maestri NE; Beaty TH; Folstein SE; Meyers DA
    Am J Med Genet; 1987 Dec; 28(4):989-97. PubMed ID: 2961260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.
    Wood E; Li K; Miller CL; Hogg RS; Montaner JS; Schechter MT; Kerr T
    Int J Epidemiol; 2005 Feb; 34(1):152-8. PubMed ID: 15561747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic analysis of the structure of predisposition to diabetes mellitus. III. Genetic heterogeneity of diabetes mellitus with different ages of onset].
    Sergeev AS; Kerimi NB; Mazovetskiĭ AG; Kuraeva TL
    Genetika; 1986 Feb; 22(2):328-35. PubMed ID: 3957027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV seroincidence and correlates of seroconversion in a cohort of male factory workers in Harare, Zimbabwe.
    Mbizvo MT; Machekano R; McFarland W; Ray S; Bassett M; Latif A; Katzenstein D
    AIDS; 1996 Jul; 10(8):895-901. PubMed ID: 8828747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factor Associated with Negative Spouse HIV Seroconversion among Sero-Different Couples: A Nested Case-Control Retrospective Survey Study in 30 Counties in Rural China.
    Tang H; Wu Z; Mao Y; Cepeda J; Morano J
    PLoS One; 2016; 11(10):e0164761. PubMed ID: 27741292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington disease in Georgia: age at onset.
    Adams P; Falek A; Arnold J
    Am J Hum Genet; 1988 Nov; 43(5):695-704. PubMed ID: 2973230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a method to estimate age-specific human immunodeficiency virus (HIV) incidence rates in developing countries using population-based seroprevalence data.
    Saidel T; Sokal D; Rice J; Buzingo T; Hassig S
    Am J Epidemiol; 1996 Aug; 144(3):214-23. PubMed ID: 8686690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    ; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
    JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.